发作性运动诱发性运动障碍的发病机制和治疗的研究进展  

Progress of pathogenesis and therapy for paroxysmal kinesigenic dyskinesia

作　　者：朱国行[1] 

机构地区：[1]复旦大学附属华山医院神经内科,上海200040

出　　处：《世界临床药物》2011年第10期591-594,共4页World Clinical Drug

摘　　要：发作性运动诱发性运动障碍(PKD)主要临床表现为运动启动时突然发生异常运动,发作时意识清楚,发作间期无神经系统阳性体征,发作频繁,临床中应注意与癫痫的鉴别。抗癫痫治疗对原发性PKD有效,一般预后良好。本文综述PKD的发病机制及其治疗的研究进展。The manifestation of paroxysmal kinesigenic dyskinesia （PKD） is abnormal movement while starting to move. During the seizure, there is no nervous system positive sign involved, the patients are conscious and episodes frequently. PKD and epilepsy should be differentiated in clinic. Usually, anti-epilepsy treatment for primary PKD is effective with generally good prognosis. This review describes the progress ofpathogenesis and therapy for PKD.

关 键 词：发作性运动诱发性运动障碍 癫痫 临床特征 药物评价 

分 类 号：R741.02[医药卫生—神经病学与精神病学] R971[医药卫生—临床医学]